Literature DB >> 20947547

Major lupus organ involvement: severe lupus nephritis.

Y Avihingsanon1, N Hirankarn.   

Abstract

Lupus nephritis is a common and severe complication of systemic lupus erythematosus. A number of patients have nephritis as a presenting feature that, in its severe form, can shortly lead to end-stage renal disease and/or death. Renal flare usually occurs a few years after the first episode and is remarkably predominant in the Asian population. Frequent monitoring for renal flare enhances early recognition and timely treatment. The mainstay therapy continues to be the prolonged use of cytotoxic/immunosuppressive drugs that have a number of undesirable effects, particularly ovarian failure and development of opportunistic infections. This review will focus on the pathogenesis and the unique genetic factors found in Asian patients with lupus nephritis. Here, we propose an appropriate management scheme for the treatment of lupus nephritis in Asian patients.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20947547     DOI: 10.1177/0961203310376522

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  7 in total

Review 1.  Lupus nephritis: review of the literature.

Authors:  Adeel Zubair; Marianne Frieri
Journal:  Curr Allergy Asthma Rep       Date:  2013-12       Impact factor: 4.806

Review 2.  Lupus erythematosus revisited.

Authors:  Annegret Kuhn; Joerg Wenzel; Marc Bijl
Journal:  Semin Immunopathol       Date:  2015-12-04       Impact factor: 11.759

3.  Biomarkers for Refractory Lupus Nephritis: A Microarray Study of Kidney Tissue.

Authors:  Thitima Benjachat; Pumipat Tongyoo; Pornpen Tantivitayakul; Poorichaya Somparn; Nattiya Hirankarn; Santitham Prom-On; Prapaporn Pisitkun; Asada Leelahavanichkul; Yingyos Avihingsanon; Natavudh Townamchai
Journal:  Int J Mol Sci       Date:  2015-06-23       Impact factor: 5.923

4.  Clinical aspects and risk factors of lupus nephritis: a retrospective study of 156 adult patients.

Authors:  Fang Yuan; Fenghua Wei; Junjie Wang; Yanwu You
Journal:  J Int Med Res       Date:  2019-09-12       Impact factor: 1.671

5.  The effect of esculentoside A on lupus nephritis-prone BXSB mice.

Authors:  Hualin Ma; Xianggui Zhang; Xinzhou Zhang; Dan Yang; Lingguo Meng; Yi Zhang; Shuyan Zhou
Journal:  Arch Med Sci       Date:  2012-10-30       Impact factor: 3.318

6.  Mannose binding lectin: a biomarker of systemic lupus erythematosus disease activity.

Authors:  Aditya K Panda; Jyoti R Parida; Rina Tripathy; Sarit S Pattanaik; Balachandran Ravindran; Bidyut K Das
Journal:  Arthritis Res Ther       Date:  2012-10-15       Impact factor: 5.156

7.  Meta-analysis of genome-wide association study identifies FBN2 as a novel locus associated with systemic lupus erythematosus in Thai population.

Authors:  Pattarin Tangtanatakul; Chisanu Thumarat; Nusara Satproedprai; Punna Kunhapan; Tassamonwan Chaiyasung; Siriwan Klinchanhom; Yong-Fei Wang; Wei Wei; Jeerapat Wongshinsri; Direkrit Chiewchengchol; Pongsawat Rodsaward; Pintip Ngamjanyaporn; Thanitta Suangtamai; Surakameth Mahasirimongkol; Prapaporn Pisitkun; Nattiya Hirankarn
Journal:  Arthritis Res Ther       Date:  2020-08-08       Impact factor: 5.156

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.